BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 115.60
-2.60 (-2.20%)
Jul 24, 2026, 5:29 PM CET
BioGaia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,581 | 1,538 | 1,423 | 1,297 | 1,104 | 785.11 | |
Revenue Growth (YoY) | 9.78% | 8.12% | 9.74% | 17.44% | 40.61% | 5.09% |
Cost of Revenue | 426.62 | 409.59 | 391.98 | 346.32 | 302.03 | 202.16 |
Gross Profit | 1,154 | 1,129 | 1,031 | 950.19 | 801.93 | 582.95 |
Selling, General & Admin | 599.7 | 560.89 | 464.28 | 402.51 | 360.62 | 234.98 |
Research & Development | 116.44 | 115.72 | 157.1 | 106.78 | 106.81 | 105.47 |
Other Operating Expenses | 2.36 | -39.51 | 14.32 | 2.25 | 28.03 | 11.97 |
Total Operating Expenses | 718.5 | 637.11 | 635.7 | 511.53 | 495.45 | 352.42 |
Operating Income | 440.23 | 412.47 | 423.37 | 443.1 | 361.46 | 253.74 |
Interest Income | 10.09 | 17.2 | 39.37 | 41.53 | 91.54 | 0.11 |
Interest Expense | -5.87 | -8.45 | -14.92 | -15.8 | -5.39 | -1.13 |
Total Non-Operating Income (Expense) | 4.22 | 8.75 | 24.45 | 25.73 | 86.15 | -1.03 |
Pretax Income | 444.45 | 421.22 | 447.82 | 468.83 | 447.61 | 252.71 |
Provision for Income Taxes | 97.22 | 88.46 | 96.43 | 103.48 | 73.84 | 56.44 |
Net Income | 347.23 | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Net Income to Common | 164.66 | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Net Income Growth | 38.92% | -5.30% | -3.82% | -2.25% | 90.44% | 9.20% |
Shares Outstanding (Basic) | 101 | 101 | 101 | 101 | 101 | 101 |
Shares Outstanding (Diluted) | 101 | 101 | 101 | 101 | 101 | 101 |
Shares Change (YoY) | 0.04% | 0.09% | 0.09% | - | - | 465.57% |
EPS (Basic) | 3.43 | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 |
EPS (Diluted) | 3.43 | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 |
EPS Growth | 21.20% | -5.46% | -3.87% | -2.16% | 90.72% | -80.73% |
Free Cash Flow | 299.67 | 303.04 | 359.46 | 377.4 | 301.03 | 215.5 |
Free Cash Flow Growth | -3.50% | -15.70% | -4.75% | 25.37% | 39.69% | 5.03% |
Free Cash Flow Per Share | 2.96 | 3.00 | 3.56 | 3.74 | 2.98 | 2.13 |
Dividends Per Share | 1.640 | 1.640 | 1.950 | 1.900 | 1.450 | 0.730 |
Dividend Growth | -15.90% | -15.90% | 2.63% | 31.03% | 98.63% | 7.04% |
Gross Margin | 73.01% | 73.37% | 72.45% | 73.29% | 72.64% | 74.25% |
Operating Margin | 27.85% | 26.82% | 29.76% | 34.18% | 32.74% | 32.32% |
Profit Margin | 21.97% | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% |
FCF Margin | 18.96% | 19.70% | 25.27% | 29.11% | 27.27% | 27.45% |
EBITDA | 464.67 | 437.13 | 448.92 | 468.38 | 385.35 | 280.98 |
EBITDA Margin | 29.40% | 28.42% | 31.55% | 36.13% | 34.91% | 35.79% |
EBIT | 440.23 | 412.47 | 423.37 | 443.1 | 361.46 | 253.74 |
EBIT Margin | 27.85% | 26.82% | 29.76% | 34.18% | 32.74% | 32.32% |
Effective Tax Rate | 21.87% | 21.00% | 21.53% | 22.07% | 16.50% | 22.33% |